AA
LLY icon

Armis Advisers’s Eli Lilly LLY Stock Holding History

Armis Advisers’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.24M Buy
3,530
+93
+3% +$95K 0.39% 43
2026
Q1 		$3.49M Buy
3,437
+387
+13% +$392K 0.34% 51
2025
Q4 		$2.77M Buy
3,050
+139
+5% +$133K 0.31% 57
2025
Q3 		$2.54M Buy
2,911
+241
+9% +$179K 0.23% 68
2025
Q2 		$2.11M Buy
2,670
+425
+19% +$330K 0.17% 111
2025
Q1 		$1.95M Buy
2,245
+1,490
+197% +$1.24M 0.18% 105
2024
Q4 		$583K Buy
+755
New +$625K 0.07% 175

Other funds holding LLY

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
ONB
Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
GIM
Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Armis Advisers's LLY Position: Q2 2026 in Review

Armis Advisers increased its Eli Lilly (LLY) stake by 2.7% in Q2 2026, buying an estimated $95K and bringing the position to 3,530 shares worth $4.24M. The position accounts for 0.39% of the portfolio, ranked #43.

Armis Advisers first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Armis Advisers held 3,530 shares of Eli Lilly worth $4.24M as of Q2 2026.
  • Armis Advisers bought 93 Eli Lilly shares in Q2 2026, an estimated $95K.
  • Eli Lilly made up 0.39% of Armis Advisers's portfolio in Q2 2026, its #43 holding.
  • Armis Advisers first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Armis Advisers's 13F filing for Q2 2026, filed 7 Jul 2026.